Second COVID booster shot does little to stop Omicron, study finds

Israeli healthcare workers who were boosted with a fourth shot of COVID-19 vaccine at the height of the Omicron wave were only marginally more protected against reinfection than their peers who had received three jabs of vaccine, researchers reported Wednesday.Compared to getting two initial doses and one booster shot of Pfizer and BioNTech’s Comirnaty vaccine,…

Share this:

Though rare, Moderna Covid vaccine recipients have higher risk of heart inflammation than Pfizer

Lalain Reyeg administers a COVID-19 booster vaccine at the Edward Hines Jr. VA Hospital on September 24, 2021 in Hines, Illinois.Scott Olson | Getty ImagesModerna’s two-dose Covid-19 vaccine is associated with a higher risk of heart inflammation than Pfizer’s, but the benefits of both companies’ shots outweigh the risks, according to a Centers for Disease…

Share this:

Patient who refused COVID vaccine was denied a heart transplant

This family photo shows D.J. Ferguson initially being treated at Milford, Mass., Regional Medical Center. Brigham and Women’s Hospital in Boston is defending itself after Ferguson’s family claimed he was denied a new heart for refusing to be vaccinated against COVID-19. Tracey Ferguson file photo/via AP hide caption toggle caption Tracey Ferguson file photo/via AP…

Share this:

Omicron variant: Pfizer starts clinical trial for modified Covid vaccine

Pfizer and BioNTech announced Tuesday that they have started a clinical trial testing a modified Covid-19 vaccine to protect against the supercontagious omicron variant of the coronavirus.The drugmakers said they aim to enroll up to 1,420 healthy adults ages 18 to 55 in the trial, which will evaluate whether the omicron-specific vaccine is safe and generates…

Share this:

Omicron-specific vaccine is coming but ‘may not matter—everybody’s going to be infected,’ says expert

An omicron-specific Covid vaccine will be ready by March but some experts warn it could be “too late” due to the variant’s highly transmissible nature.On Monday, Pfizer CEO Albert Bourla told CNBC that its vaccine with BioNTech that targets omicron — and other variants that are currently circulating — will be ready for distribution by…

Share this:

CDC Finds Vaccinated People Rarely Die From Covid — Unless They Have Risk Factors

Topline Vaccinated Americans face an extremely low risk of dying from Covid-19 or developing severe illness, and most of those who do succumb to the disease have multiple underlying health conditions, according to a study released Thursday by the Centers for Disease Control and Prevention cast as evidence that vaccines work — but which recommends…

Share this:

COVID Vaccine in Pregnancy Not Tied to Adverse Outcomes

Pregnant women who received a COVID-19 vaccine faced no additional risks of adverse birth outcomes compared to those who were not vaccinated, according to a retrospective cohort study. COVID-19 vaccination in pregnancy was not associated with an increased risk of preterm birth (adjusted hazard ratio [aHR] 0.91, 95% CI 0.82-1.01) or of small-for-gestational-age (SGA) at…

Share this:

U.S. FDA clears Pfizer’s COVID-19 booster shot for 12-year-olds

Brendan Lo (13) receives a dose of the Pfizer-BioNTech vaccine for the coronavirus disease (COVID-19) at Northwell Health’s Cohen Children’s Medical Center in New Hyde Park, New York, U.S., May 13, 2021. REUTERS/Shannon StapletonRegister now for FREE unlimited access to Reuters.comJan 3 (Reuters) – The U.S. Food and Drug Administration has authorized the use of…

Share this:

Why the CDC now recommends mRNA COVID vaccines over J&J’s

The Moderna and Pfizer-BioNTech COVID vaccines are preferred over the Johnson & Johnson vaccine to prevent COVID-19 in people 18 years of age and over, the US Centers for Disease Control and Prevention now says. The agency’s expert vaccine panel, the Advisory Committee on Immunization Practices, voted unanimously on Thursday to change its official recommendations.…

Share this:

Two-dose vaccines induce lower antibodies against Omicron, study finds

Health workers prepare doses of the Pfizer-BioNTech COVID-19 vaccine at an inoculation centre in Naples, Italy, January 8, 2021. REUTERS/Ciro De LucaDec 13 (Reuters) – Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be…

Share this:

Protection offered by booster shot beats ‘natural immunity,’ study suggests

Public health officials have been struggling to persuade eligible Americans to get their COVID-19 booster shots. New research could help them make the case that the extra dose will provide substantially more protection — even if they’ve also recovered from a coronavirus infection. A small study that’s among the first to track people’s protective antibodies…

Share this:

American vaccine disinformation used as ‘Trojan horse’ for far right in New Zealand

CHRISTCHURCH, New Zealand — When Josephine Bartley, a councilor in Auckland, New Zealand, heard that a local Covid-19 vaccination clinic had been vandalized in early November, she drove over to survey the damage. After speaking to the owners and helping them connect with local law enforcement, she noticed three men loitering near her parking spot.“Some…

Share this:

Pfizer’s Covid-19 Shot Offers 100% Long-Term Protection For Young Teens, Trial Shows

Topline Pfizer and BioNTech announced Monday their jointly-developed coronavirus vaccine offered strong long-term protection against Covid-19 in teenagers aged 12 to 15, data the companies said will support planned submissions for full regulatory approval in the U.S. and around the world.  Pfizer said its Covid-19 vaccine provides 100% protection in teens 12-15 AFP via Getty…

Share this: